Don't Miss These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street's Most Accurate Analysts

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy. Here's a look at the most recent high-yield dividend stock ratings from the most accurate Wall Street analysts, according to Benzinga's Analyst Stock Ratings.

Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector.

Organon & Co. OGN

• Dividend Yield: 9.97%
• Piper Sandler analyst David Amsellem maintained an Overweight rating and cut the price target from $32 to $22 on Nov. 22, 2023. This analyst has an accuracy rate of 64%.
• B of A Securities analyst Jason Gerberry downgraded the stock from Neutral to Underperform and cut the price target from $37 to $25 on Oct. 14, 2023. This analyst has an accuracy rate of 70%.
• Recent News: Organon, last month, posted weaker-than-expected results for the third quarter.

CVS Health Corporation CVS

• Dividend Yield: 3.61%
• Morgan Stanley analyst Erin Wright maintained an Overweight rating and cut the price target from $110 to $100 on Nov. 2, 2023. This analyst has an accuracy rate of 77%.
• Raymond James analyst John Ransom maintained an Outperform rating and cut the price target from $90 to $85 on Aug. 4, 2023. This analyst has an accuracy rate of 71%.
• Recent News: CVS Health recently reiterated FY23 guidance, issued FY24 guidance and announced a quarterly dividend of 66.5 cents per share.

Baxter International Inc. BAX

• Dividend Yield: 3.19%
• JP Morgan analyst Robbie Marcus maintained a Neutral rating and cut the price target from $49 to $36 on Oct. 31, 2023. This analyst has an accuracy rate of 70%.
• Citigroup analyst Joanne Wuensch maintained a Neutral rating and lowered the price target from $47 to $45 on Aug. 21, 2023. This analyst has an accuracy rate of 73%.
• Recent News: Baxter International, last month, posted third-quarter revenue of $3.71 billion, which beat the consensus of $3.69 billion, up 3% Y/Y on a reported basis and 2% on a constant currency.

Read More: Investor Optimism Improves Further Ahead Of Inflation Data; Dow Gains For Third Straight Day